resorcinol has been researched along with cannabidiol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Appendino, G; Giana, A; Gibbons, S; Grassi, G; Pagani, A; Rahman, MM; Smith, E; Stavri, M | 1 |
Ebisawa, J; Okushima, Y; Watanabe, K; Yamamoto, I; Yamaori, S | 1 |
Okushima, Y; Watanabe, K; Yamamoto, I; Yamaori, S | 1 |
Appendino, G; Caprioglio, D; Chianese, G; Collado, JA; Lopatriello, A; Mattoteia, D; Minassi, A; Munoz, E; Negri, R; Pollastro, F; Taglialatela-Scafati, O | 1 |
4 other study(ies) available for resorcinol and cannabidiol
Article | Year |
---|---|
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
Topics: Acetylation; Anti-Bacterial Agents; Cannabinoids; Cannabis; Magnetic Resonance Spectroscopy; Methicillin Resistance; Methylation; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Structure-Activity Relationship | 2008 |
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
Topics: Aryl Hydrocarbon Hydroxylases; Cannabidiol; Cannabinol; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Dronabinol; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Microsomes, Liver; Middle Aged; Resorcinols | 2011 |
Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol.
Topics: Animals; Cannabidiol; Cytochrome P-450 CYP1A1; Enzyme Activation; Enzyme Inhibitors; Humans; Resorcinols; Structure-Activity Relationship | 2014 |
The Oxidation of Phytocannabinoids to Cannabinoquinoids.
Topics: Cannabidiol; Cannabinoids; Oxidation-Reduction; PPAR gamma; Quinones; Reproducibility of Results; Resorcinols | 2020 |